Patients' experiences of long-acting injectable antipsychotics: a qualitative study

被引:5
|
作者
Chiu, Lin-Ling [1 ]
Liu, Chun-Hao [2 ,3 ]
Chu, Chun-Lin [4 ]
Lin, Huang-Li [2 ]
Lii, Shu-Chung [5 ]
机构
[1] Chang Gung Univ, Coll Med, Sch Med, Taoyuan, Taiwan
[2] Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp Linkou, Dept Child Psychiat, Taoyuan, Taiwan
[4] Chang Gung Mem Hosp Taoyuan, Dept Psychiat, Taoyuan, Taiwan
[5] Chang Gung Univ, Coll Med, Humanist & Social Med Div, 259 Wen Hua 1st Rd, Taoyuan 333, Taiwan
关键词
antipsychotics; experience; long-acting injectable; LAI; qualitative research; SCHIZOPHRENIA; INJECTIONS; PROGRAM;
D O I
10.2147/NDT.S206154
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: In this study, we applied a qualitative approach to explore patients' subjective experiences of long-acting injectable antipsychotics (LAIs). Methods: Patients undergoing psychiatric treatment from the chronic ward or outpatient department of a medical center in northern Taiwan who had experience with LAI treatment were enrolled. Information was obtained through semi-structured in-depth interviews. The interviews were audio-recorded and then translated verbatim, and the data were collected and analyzed concurrently to develop major themes and categories. Result: In total, 14 participants (8 female) were interviewed. In a bio-psycho-social model, the participants used LAIs as a method to become "normal," in order to achieve a balance between the "effects" and "side effects" that may influence their daily lives. Their past experiences constructed their concepts about and expectations regarding LAIs, and their relationships with their family members and co-workers also modeled their experiences. Conclusion: In our study, we sought to understand the experience of LAI in the daily life context of the patients. We attempted to use a bio-psycho-social model to evaluate the subjective experience of the patients; an improved understanding can help mental health specialists gain a closer insight into patient experience.
引用
收藏
页码:1797 / 1804
页数:8
相关论文
共 50 条
  • [1] LONG-ACTING INJECTABLE ANTIPSYCHOTICS
    Johnston, Karen
    Sliwa, Jennifer Kern
    Bossie, Cynthia A.
    Kim, Edward
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2019, 57 (11) : 5 - 5
  • [2] A Qualitative Study of Experiences With and Perceptions Regarding Long-Acting Injectable Antipsychotics: Part I-Patient Perspectives
    Iyer, Srividya
    Banks, Nicola
    Roy, Marc-Andre
    Tibbo, Phil
    Williams, Richard
    Manchanda, Rahul
    Chue, Pierre
    Malla, Ashok
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2013, 58 (05): : 14S - 22S
  • [3] Identifying patients for treatment with long-acting injectable antipsychotics
    Ramachandra, R. S. R.
    EUROPEAN PSYCHIATRY, 2008, 23 : S167 - S167
  • [4] A Qualitative Study of Experiences With and Perceptions Regarding Long-Acting Injectable Antipsychotics: Part II-Physician Perspectives
    Iyer, Srividya
    Banks, Nicola
    Roy, Marc-Andre
    Tibbo, Phil
    Williams, Richard
    Manchanda, Rahul
    Chue, Pierre
    Malla, Ashok
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2013, 58 (05): : 23S - 29S
  • [5] LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA: A 18 MONTHS STUDY
    Romero Guillena, S. L.
    Gotor, F.
    Plasencia Garcia de Diego, B. O.
    Navarro Pablo, R.
    Santamaria, O.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [6] TRACING THE AFFORDANCES OF LONG-ACTING INJECTABLE DEPOT BUPRENORPHINE: A QUALITATIVE STUDY OF PATIENTS' EXPERIENCES IN AUSTRALIA
    Barnett, Anthony
    Savic, Michael
    Lintzeris, Nicholas
    Bathish, Ramez
    Arunogiri, Shalini
    Dunlop, Adrian J.
    Haber, Paul S.
    Graham, Robert
    Hayes, Vicky
    Lubman, Dan I.
    DRUG AND ALCOHOL REVIEW, 2021, 40 : S18 - S18
  • [7] Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients' experiences in Australia
    Barnett, Anthony
    Savic, Michael
    Lintzeris, Nicholas
    Bathish, Ramez
    Arunogiri, Shalini
    Dunlop, Adrian J.
    Haber, Paul
    Graham, Robert
    Hayes, Vicky
    Lubman, Dan, I
    DRUG AND ALCOHOL DEPENDENCE, 2021, 227
  • [8] Discharge rates for patients initiated on long-acting injectable antipsychotics
    Singh, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S477 - S477
  • [9] EVIDENCE FOR THE USE OF LONG-ACTING INJECTABLE ANTIPSYCHOTICS
    Amladi, Anjani
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S44 - S44
  • [10] Long-Acting Injectable Antipsychotics: Recommendations for Clinicians
    Malla, Ashok
    Tibbo, Phil
    Chue, Pierre
    Levy, Emmanuelle
    Manchanda, Rahul
    Teehan, Michael
    Williams, Richard
    Iyer, Srividya
    Roy, Marc-Andre
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2013, 58 (05): : 30S - 35S